Insight Molecular Diagnostics logo

Insight Molecular Diagnostics

IMDX | NASDAQ
Chart Builder DCF Calculator
$1.86
-$0.28 (-13.08%)
At close: Nov 16, 2026, 4:00 PM ET
$1.53
-$0.33 (-17.74%)
After-hours: Nov 16, 2026, 7:55 PM ET
-13.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #720/1021 (Top 71%)

Key Statistics

Market Data

Market Cap $68.36M
1D Range
1.85 2.11
52W Range
1.85 7.50

Valuation (TTM)

PE -1.22
PB -3.21
EV/EBITDA -1.14

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $12.00
Loading financial charts...

Profile

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identificat...

Sector Healthcare
Employees 57
IPO Date Dec 30, 2015
Website imdxinc.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.19
Beat +19.49%
REV
$559K
Beat +128.84%
Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$12.00
Upside
+545.16%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.